Childhood acute myeloid leukemia aml is a type of cancer in which the bone marrow makes a large number of abnormal blood cells. Juvenile myelomonocytic leukemia jmml is a serious chronic leukemia cancer of the blood that affects children mostly aged 4 and younger. It accounts for 23% of all childhood hematologic malignancies with. Peripheral blood film examination showed leukoerythroblastosis with leukocytosis, absolute monocytosis, microcytic hypo chromic anemia, and thrombocytopenia.
In cmml, the change affects the normal development of a type of white blood cell called a monocyte. Juvenile myelomonocytic leukemia jmml is a unique, aggressive hematopoietic disorder of infancyearly childhood caused by excessive proliferation of cells. Jmml juvenile myelomonocytic leukemia danafarberboston. Chronic myelomonocytic leukemia cmml and juvenile myelomonocytic leukemia jmml2 chronic myelomonocytic leukemia cmml cmml is a clonal disorder, which means that it begins with one or more changes mutations to the dna of a single cell that multiplies uncontrollably. Detection of subclonal setbp1 and jak3 mutations in. In the past, due to the lack of knowledge about this disease and the. Treatment of children with juvenile myelomonocytic. Monocytes represent about 5 to 10 percent of the cells in normal human blood. Heterogeneous diseasepropagating stem cells in juvenile. However, the condition is rare and represents approximately 3 % of all leukemias during childhood. Juvenile myelomonocytic leukemia jmml is a rare clonal myeloproliferative disorder mpd of early childhood 1.
Juvenile myelomonocytic leukemia jmml is a clonal hematopoietic disorder of early childhood characterized by hepatosplenomegaly, granulocytosis, and monocytosis with left shift and dysplastic changes, elevated hemoglobin f levels, and frequent skin involvement. The who categorizes cmml into the following two subtypes based on the percentage of blast cells found in the blood and bone marrow. Juvenile myelomonocytic leukemia jmml is a malignant hematopoietic disorder whose proliferative component is a result of ras pathway deregulation caused by somatic mutation in the ras or ptpn11. Childhood leukemia is the most common childhood cancer, accounting for 29% of cancers in children aged 014 in 2018. In an effort to resolve most of the above described discrepancies, the international juvenile myelomonocytic leukemia working group has recently proposed the term juvenile myelomonocytic leukemia jmml. Somatic mutations in ptpn11 in juvenile myelomonocytic. Chronic myelomonocytic leukemia and juvenile myelomonocytic. Some of the monocytes and myelocytes mature into normal white blood cells, but many of them. Emi h caywood, md e anders kolb, md section editor.
It is an extremely rare disease with approximately 50 new cases occurring in the united states each year. The median age at diagnosis was 20 months range, 185 months. The course of jmml is quite variable with rd of patients having rapidly progressive course, rd having relatively indolent course while remaining rd have. Pdf diagnosis and treatment of juvenile myelomonocytic leukemia. Some early cancers may have signs and symptoms that can be noticed, but thatis not. Juvenile myelomonocytic leukemia jmml is fairly rare, so it has been hard to study which treatment might be best. Instructions for juvenile myelomonocytic leukemia prehct. How i treat juvenile myelomonocytic leukemia american society of. The cellular hierarchy in jmml is poorly characterized, including the identity of leukemia stem cells lscs. Juvenile myelomonocytic leukemia prehct data form 2015 version 1. Juvenile myelomonocytic leukemia jmml is a malignant clonal neoplasm of an abnormal multipotent hematopoietic progenitor cell characterized by proliferation of differentiating myeloid and monocytic precursor cells with a moderately elevated proportion of myeloblasts 1,2. Childhood leukemia early detection, diagnosis, and types cancer. Jmml is a rare, serious chronic form of cancer of the blood in children frequently boys, aged. Juvenile myelomonocytic leukaemia jmml is a very rare type of slowly developing chronic blood disorder that occurs in young children.
But in leukemia, wbcs turn cancerous and multiply when they shouldnt, resulting in too many abnormal wbcs, which then interfere with the bodys ability to function normally. Jun 20, 2016 juvenile myelomonocytic leukemia jmml is a very rare disorder with an incidence rate of 1. Juvenile myelomonocytic leukemia jmml is a rare fatal hematopoietic disorder of early childhood. Whereas sporadic jmml is known to be aggressive, jmml occurring in patients with ns is often considered as benign and transitory. To view this resource, click view and print as pdf on the right. Jmml shares several phenotypic features with its adult counterpart proliferative, chronic myelomonocytic leukemia pcmml.
Acute myeloblastic leukemia aml is a group of malignant bone marrow neoplasms of myeloid precursors of white blood cells. Juvenile chronic myelomonocytic leukemia definition a rare form of childhood leukemia in which cancer cell s often spread into tissue s such as the skin, lung and intestine s. Pubmed is a searchable database of medical literature and lists journal articles that discuss juvenile myelomonocytic leukemia. Acute myelomonocytic leukemia amlm4 is a common type of pediatric aml. Castleberry, personal communication, december 1996, which has been accepted and widely used in some recent publications. Juvenile myelomonocytic leukemia jmml is a rare childhood cancer. Juvenile myelomonocytic leukemia jmml is a rare type of blood cancer that occurs when bone marrow production of white blood cells becomes severely disregulated. To investigate clinical features, diagnosis, treatment strategies and prognosis of juvenile myelomonocytic leukemia jmml. Chronic myelomonocytic leukemia cmml cmml is a clonal disorder, in which a group of identical cells, sharing a common ancestry, multiply uncontrollably.
Juvenile myelomonocytic leukaemia jmml other conditions. The name jmml now encompasses all diagnoses formerly referred to as juvenile chronic myeloid leukemia jcml, chronic myelomonocytic leukemia of infancy, and infantile monosomy 7 syndrome. Juvenile myelomonocytic leukemia jmml is a rare and serious form of childhood leukemia blood cancer. Juvenile myelomonocytic leukaemia jmml get information on what jmml is, the symptoms and what treatment is available. Juvenile myelomonocytic leukemia nicklaus childrens. Juvenile myelomonocytic leukemia jmml is a typically aggressive myeloid neoplasm of childhood that is clinically characterized by overproduction of monocytic cells that can infiltrate organs. Case study juvenile myelomonocytic leukaemia and noonan syndrome. These myelocytes, monocytes, and blasts crowd the normal cells.
Pdf juvenile myelomonocytic leukemia jmml is a rare fatal hematopoietic disorder of early childhood. Juvenile myelomonocytic leukemia, genetic diagnosis, gene mutation introduction juvenile myelomonocytic leukemia jmml is a rare malignant blood system disease among children. In both conditions, prognosis and standard treatment for autoimmune phenomena remain poorly understood. Click on the link to view a sample search on this topic. Molecular determinants of juvenile myelomonocytic leukemia. Key words hematopoietic stem cell transplantation, juvenile myelomonocytic leukemia, mutation, stem cell. It represents about 23 % of childhood leukemias with about 75 % cases occurring below 3 years of age 1, 2. In cmml the change affects the normal development of a. Juvenile myelomonocytic leukemia jmml is a rare and aggressive blood cancer that affects infants and young children. It is sometimes considered a myeloproliferative neoplasm. Aml or mds may occur after treatment with certain chemotherapy drugs andor radiation therapy. This current topic of jmml does not include discussion on rasassociated autoimmune leukoproliferative disorder rald, which is a nonmalignant disorder with myelomonocytic hyperplasia and somatic mutations in kras or nras, often showing clinical overlap with jmml calvo et al.
Juvenile myelomonocytic leukemia jmml is a unique, aggressive hematopoietic disorder of infancyearly childhood caused by excessive proliferation. Background infants with noonan syndrome ns are predisposed to developing juvenile myelomonocytic leukaemia jmml or jmmllike myeloproliferative disorders mpd. Jmml predominately affects young children, most often developing in children under the age of 4. Somatic defects in either ras, ptpn11 or nf1 genes involved in this. Juvenile myelomonocytic leukemia jmml is an aggressive hematopoietic disorder of infancyearly childhood characterized by hepatosplenomegaly, granulocytosis, and monocytosis with left shift and dysplastic changes, elevated hemoglobin f levels, and frequent skin involvement. The average age at diagnosis is around 2 years old, although some children are found to have jmml just days after being born. However, little information is available regarding the occurrence and characteristics of jmml in ns. Juvenile myelomonocytic leukemia jmml is a unique, aggressive hematopoietic disorder of infancyearly childhood caused by excessive proliferation of cells of monocytic and granulocytic lineages. In children with jmml, the bone marrow the soft, spongy center of the bones responsible for creating blood cells produces immature white blood cells that grow too rapidly and. Childhood leukemia early detection, diagnosis, and types.
Juvenile myelomonocytic leukemia genetic and rare diseases. Jmml, juvenile chronic myeloid leukemia, chronic myelomonocytic leukemia of infancy, infantile monosomy 7 syndrome. Apr 28, 2003 we report here that individuals with noonan syndrome and juvenile myelomonocytic leukemia jmml have germline mutations in ptpn11 and that somatic mutations in ptpn11 account for 34% of non. Diagnosis and treatment of juvenile myelomonocytic leukemia xiongyu liaoa,b, kunyin qiu a,b, jianpei fanga,b, ruohao wua,b, shuyi guoa,b, ke huanga,b and dunhua zhoua,b adepartment of paediatrics, sun yatsen memorial hospital, sun yatsen university, guangzhou, peoples republic of china. Aml starts from the myeloid cells that normally form white blood cells other than lymphocytes, red blood cells, or platelets. Recent studies clearly show that the deregulated activation of the ras signaling pathway plays a central role in the pathogenesis of jmml. To define the status of juvenile myelomonocytic leukemia jmml patients in turkey, in terms of time of diagnosis, clinical characteristics, mutational studies, clinical course and. Feb 12, 2015 juvenile myelomonocytic leukemia jmml is a unique, aggressive hematopoietic disorder of infancyearly childhood caused by excessive proliferation of cells of monocytic and granulocytic lineages. Definition monoclonal hematopoietic disorder of childhood characterized by proliferation of the granulocytic and monocytic lineages erythroid and megakaryocytic abnormalities common bone marrow stem cell with multilineage. The clinical data of 21 patients with jmml who were diagnosed in our hospital from january 20 to may 2018 were retrospectively analyzed. News release title detection of subclonal setbp1 and jak3 mutations in juvenile myelomonocytic leukemia using droplet digital pcr key points. Original article two reports of juvenile myelomonocytic. Juvenile myelomonocytic leukaemia and noonan syndrome.
Juvenile myelomonocytic leukemia jmml is a type of blood cancer that affects young children. It is rare and most commonly occurs in children under the age of four. Juvenile myelomonocytic leukemia blood american society. Chronic myelomonocytic leukemia cmml and juvenile myelomonocytic leukemia jmml are uncommon blood cancers that are classified by the world health. It is characterized by overproduction of myelocytes and monocytes. Diagnosis and treatment of juvenile myelomonocytic leukemia. This type of leukemia, also called acute myelogenous leukemia, acute myelocytic leukemia, or acute nonlymphocytic leukemia, accounts for most of the remaining cases of childhood leukemia. There is no clear single best chemotherapy treatment for this leukemia. Fs17 chronic myelomonocytic leukemia cmml and juvenile myelomonocytic leukemia jmml facts i page 1 revised may 2016 chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia facts no. A stem cell transplant is the treatment of choice when possible, as it offers the best chance to cure jmml. Jmml predominately affects young children, most often developing in children under the age of. Juvenile myelomonocytic leukemia jmml is an aggressive childhood myeloproliferative disorder characterized by the overproduction of myelomonocytic cells. Treatment of children with juvenile myelomonocytic leukemia. This current topic of jmml does not include discussion on rasassociated autoimmune leukoproliferative disorder rald, which is a nonmalignant disorder with myelomonocytic hyperplasia and somatic mutations in kras or nras, often showing.
Juvenile myelomonocytic leukemia jmml childrens hospital. However, little information is available regarding the occurrence and characteristics of. Juvenile myelomonocytic leukemia jmml is a very rare disorder with an incidence rate of 1. Chronic myelomonocytic leukemia cmml cmml is a clonal disorder, which means that it begins with one or more changes mutations to the dna of a single cell that multiplies uncontrollably. Juvenile myelomonocytic leukemia jmml is a rare cancer of the blood that affects young children. Juvenile myelomonocytic leukemia jmml is a form of leukemia in which myelomonocytic cells are overproduced. In the past, due to the lack of knowledge about this disease and the poor effect of conventional chemotherapy, the clinical diag.
Chronic myelomonocytic leukemia cmml and juvenile myelomonocytic leukemia jmml are uncommon blood cancers that are classified by. There are multiple forms of leukemia that occur in children, the most common being acute lymphoblastic leukemia all followed by acute myeloid leukemia aml. Childhood leukemia is leukemia that occurs in a child and is a type of childhood cancer. This information from the leukemia and lymphoma society explains chronic myelomonocytic leukemia cmml and juvenile myelomonocytic leukemia jmml diagnosis, treatment, clinical trials and support resources. We are presenting a case of 9monthold female child who was admitted with abdominal distension, irritability, and hepatosplenomegaly. Some early cancers may have signs and symptoms that can be noticed, but thatis not always the case. Jmml can happen spontaneously by chance or can be associated with other genetic disorders in some children. Facs and singlecell rnasequencing reveal marked heterogeneity of jmml hematopoietic stemprogenitor cells hspcs, including an. Aug 22, 2012 juvenile myelomonocytic leukemia jmml is a rare hematopoietic malignancy of early childhood with features characteristic of both myelodysplastic and myeloproliferative disorders. Chronic myelomonocytic leukemia cmml and juvenile myelomonocytic leukemia jmml 2. Molecular aberrations in 107 children with myelodysplastic. Leukemia and other diseases of the blood and bone marrow may affect red blood cells, white blood cells, and platelets. Jmml occurs when too many blood stem cells become white blood cells called monocytes and myelocytes.
Juvenile myelomonocytic leukemia jmml is a rare hematopoietic malignancy of early childhood with features characteristic of both myelodysplastic and myeloproliferative disorders. Peripheral blood film examination showed leukoerythroblastosis with leukocytosis, absolute monocytosis, microcytic hypo chromic anemia, and. Juvenile myelomonocytic leukemia jmml is a rare form of blood cancer. Juvenile myelomonocytic leukemia juvenile myelomonocytic leukemia jmml is a clonal hematopoietic disorder of early childhood characterized by hepatosplenomegaly, granulocytosis, and monocytosis with left shift and dysplastic changes, elevated hemoglobin f levels, and frequent skin involvement.
Jmml happens when types of white blood cells called monocytes and myelocytes do not mature normally. Juvenile myelomonocytic leukemia jmml is a pluripotent hematopoietic stem cell that can cause erythroid hyperplasia, abnormal platelet count, abnormal lymphocyte function, myelodysplastic syndrome mds and myeloproliferation. Juvenile myelomonocytic leukemia jmml is a cancer of the white blood cells. The first case report of jmml was published in 1924, 1 followed by additional case descriptions and small series of children with chronic granulocytic leukemia. Childhood acute myeloid leukemiaother myeloid malignancies.
Blasts plus promonocytes account for pdf on the right. Juvenile myelomonocytic leukemia jmml is a poor prognosis childhood leukemia usually caused by germline or somatic rasactivating mutations. Approximately 90% of patients carry either somatic or germline mutations of ptpn11, kras, nras, cbl, or nf1 in their leukemic cells. It happens when immature blood cells called blasts make too many myelocytes and monocytes two types of white blood cells.
Juvenile myelomonocytic leukemia jmml is a rare childhood cancer that usually occurs in children younger than 2 years old. The peripheral blood and bone marrow are always involved. Fs17 chronic myelomonocytic leukemia cmml and juvenile myelomonocytic leukemia jmml facts i page 2 i myeyi eeia mm ad veie myeyi eeia mm facts which form clots to help stop bleeding after an injury. Juvenile myelomonocytic leukemia a bona fide rasopathy. Myelodysplastic syndrome, juvenile myelomonocytic leukemia. Dysplasia in one or more myeloid lineages most common demonstration of an aquired clonal cytogenetic or molecular genetic abnormality in the marrow, pdf juvenile myelomonocytic leukemia jmml is a rare fatal. Juvenile myelomonocytic leukemia jmml is a very rare dis. Patients with juvenile myelomonocytic leukemia due to germline cbl mutation 10% to 15% may have a subacute course occasionally associated with autoimmune disorders, which may resemble rasassociated autoimmune lymphoproliferative disorder. Jmml, a disorder with excessive proliferation of myelomonocytic cells, constitutes approximately 30% of childhood cases of mds and 2% of leukemia 1,2.
Among the 21 children with jmml, 16 were male and 5 were female. Pdf diagnosis and treatment of juvenile myelomonocytic. Jun 10, 2012 juvenile myelomonocytic leukemia jmml is a rare fatal hematopoietic disorder of early childhood. Somatic defects in either ras, ptpn11 or nf1 genes involved in this pathway.
784 1366 518 1254 353 964 1346 1041 653 356 1615 1230 920 609 185 1492 144 1236 513 610 823 247 1008 963 284 1605 1425 296 189 715 1463 1294 1104 781 331 1449 862